EUROAPI announced that it has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company. As part of this collaboration, EUROAPI will supply its client with a key veterinary product. The total contract value is expected to range between EUR 130 million and 150 million, over the 2025-2029 period.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 EUR | -0.34% |
|
-8.98% | -49.39% |
07/06 | EuroAPI appoints mediator to help restructure pile of debt, shares drop | RE |
07/06 | Euroapi: ad hoc mandate for the financing of Focus-27 | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.39% | 296M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- EAPI Stock
- News EUROAPI
- EUROAPI Enters into Contract Manufacturing Organization Agreement with Global Animal Health Company